Clinical Trial Update: Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adipose tissue-derived mesenchymal stem cell (AD-MSC) therapy for female sexual dysfunction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Sexual Dysfunction

Drugs mentioned

• Adipose tissue-derived mesenchymal stem cell therapy (AD-MSC)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Sexual Dysfunction Female | Phase 2 | Status: RECRUITING